Ceapro Inc
XTSX:CZO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Grupo Greening 2022 SA
MAD:GGR
|
ES |
Ceapro Inc
Total Equity
Ceapro Inc
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Ceapro Inc
XTSX:CZO
|
Total Equity
CA$27.9m
|
CAGR 3-Years
5%
|
CAGR 5-Years
4%
|
CAGR 10-Years
61%
|
|
|
Burcon NutraScience Corp
TSX:BU
|
Total Equity
-CA$2.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
EcoSynthetix Inc
TSX:ECO
|
Total Equity
$38.6m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-6%
|
|
|
5N Plus Inc
TSX:VNP
|
Total Equity
$199m
|
CAGR 3-Years
21%
|
CAGR 5-Years
11%
|
CAGR 10-Years
7%
|
|
|
Nano One Materials Corp
TSX:NANO
|
Total Equity
CA$22.5m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
32%
|
|
|
Neo Performance Materials Inc
TSX:NEO
|
Total Equity
$390m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
Ceapro Inc
Glance View
Ceapro, Inc. engages in the development and marketing of natural products for personal care, cosmetic, human, and animal health industries. The company is headquartered in Edmonton, Alberta. The firm's primary business activities relate to the development and marketing of various health and wellness products and technology relating to plant extracts. The firm operates through two segments: the active ingredient product technology industry and the cosmeceutical industry. The firm is engaged in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. The company supports the use of its extracts in cosmeceutical, nutraceutical and therapeutic products for humans and animals. Its pipeline Oat Beta Glucan and Avenanthramides. The Company’s wholly owned subsidiaries include Ceapro Technology Inc., Ceapro Active Ingredients Inc., Ceapro BioEnergy Inc., Ceapro (P.E.I) Inc., Ceapro USA Inc., and JuventeDC Inc.
See Also
What is Ceapro Inc's Total Equity?
Total Equity
27.9m
CAD
Based on the financial report for Dec 31, 2023, Ceapro Inc's Total Equity amounts to 27.9m CAD.
What is Ceapro Inc's Total Equity growth rate?
Total Equity CAGR 10Y
61%
Over the last year, the Total Equity growth was -14%. The average annual Total Equity growth rates for Ceapro Inc have been 5% over the past three years , 4% over the past five years , and 61% over the past ten years .
